Start your own journey to clinic

Please provide us with a few details so that we can match you with the right expert in your field.


Thank you, your request has been received.

We're busy connecting you with an expert, who will be in touch as soon as possible.

Oops! Something went wrong while submitting the form. Please try again or email us at


Novel Assays to enhance Spatial Biomarker Discovery and development

Spatial interrogation of biomarkers within the tumour microenvironment provides valuable insight into tumour progression and drug response. Development of reliable multiplex IHC / IF staining assays is however complex, time-consuming, and relies upon antibody suitability. To address this, we aimed to adopt two novel assays; PhenoCodeTM Signature Panels and RNAscope + multiplex IHC, which offer an alternative approach to biomarker discovery and development. PhenoCodeTM Signature Panels greatly reduce panel optimisation times by utilising barcode-based antibody chemistry to apply a single pre-optimised cocktail of six antibodies in one step.RNAscope + multiplex IHC enables the detection of multiple RNA and protein biomarkers on the same tissue section, providing a solution when a suitable antibody cannot be sourced for a particular biomarker. Here we test the robustness of a PhenoCodeTM panel and demonstrate the staining of two RNAscope / protein panels as proof of principle

Alternatively, search our entire resource library below

Show filters
View all
Category one
Category two
Category three
Category four
Resource type
Related service line
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Showing 0 items